Tumor necrosis factor gene and microsatellite polymorphism in chronic inflammatory bowel diseases.

被引:0
作者
Heresbach, D
Ababou, A
Bourienne, A
Alizadeh, M
Quelvennec, E
Pagenault, M
Dabadie, A
HeresbachLeBerre, N
Campion, JP
Launois, B
Gosselin, M
Genetet, B
Bretagne, JF
Semana, G
机构
[1] CHRU PONTCHAILLOU,SERV HEPATOGASTROENTEROL,RENNES,FRANCE
[2] CHRU PONTCHAILLOU,SERV PEDIAT,RENNES,FRANCE
[3] CHRU PONTCHAILLOU,CLIN CHIRURG B,RENNES,FRANCE
[4] ETABLISSEMENT TRANSFUS SANGUINE BRETAGNE EST,LAB UNIV IMMUNOL,RENNES,FRANCE
来源
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 1997年 / 21卷 / 8-9期
关键词
inflammatory bowel disease; Crohn's disease; microsatellites; tumor necrosis factor;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives. - Multiplex family studies have excluded chromosome 6 as a candidate gene of susceptibility to inflammatory bowel disease. However one recent study suggested that a gene involved in the pathogenesis of Crohn's disease is located on chromosome 6 confering to a microsatellite allelic combination (a2, b1, c2, d4, e1) a strong genetic risk factor in Crohn's disease. The aim of our study was to determine simultaneously the polymorphisms of the TNF microsatellites and of the the genes coding for TNF synthesis in patients with inflammatory bowel disease. Patients and methods. - Sixty patients with ulcerative colitis, 100 patients with Crohn's disease were compared to 64 healthy ethnically matched controls. Five TNF microsatellite loci (a, b, c, d, e) were typed using polymerase chain reaction PCR, and two dimorphisms of TNF alpha and TNF beta (intron 1) were studied by restriction fragment length polymorphism (RFLP). Results. - Allelic frequencies of TNF microsatellites and of TNF alpha and beta genes were similar in Crohn's disease, ulcerative colitis and controls. Five loci microsatellite haplotypes, especially a2 b1 c2 d4 e1 allelic combination, were not more frequent in Crohn's disease (25 %) compared to ulcerative colitis (27 %) or controls (20 %). Subgroups stratification according to clinical characteristics did not modify haplotype frequencies. Analysis of our data taking simultaneously into account the MHC alleles (DRB1*01 or DRB1*04) did not modify our data ; however it suggested that extended haplotype on short arm of chromosome 6 differed between patients and controls. Linkage disequilibrium (Delta = -360.10(-4); P < 0.01) between a2, b1, c2, d4, e1 allelic combination and DRB1*04 allele was observed only in Crohn's disease. Conclusion. - Percentages of patients with Crohn's disease or ulcerative colitis carrying TNF microsatellite or TNF alpha and beta gene haplotypes were similar to those of healthy controls. These data argue against involvement of the TNF locus without exclusion of short arm of chromosome 6 implication in Crohn's disease pathogenesis.
引用
收藏
页码:555 / 561
页数:7
相关论文
共 50 条
  • [21] Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
    Billmeier, Ulrike
    Dieterich, Walburga
    Neurath, Markus F.
    Atreya, Raja
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (42) : 9300 - 9313
  • [22] Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
    Ulrike Billmeier
    Walburga Dieterich
    Markus F Neurath
    Raja Atreya
    World Journal of Gastroenterology, 2016, (42) : 9300 - 9313
  • [23] Expression of epithelial growth factor receptor, tumor necrosis factor-α and nuclear factor κB in inflammatory bowel diseases
    Durko, Lukasz
    Stasikowska-Kanicka, Olga
    Wagrowska-Danilewicz, Malgorzata
    Danilewicz, Marian
    Malecka-Panas, Ewa
    PRZEGLAD GASTROENTEROLOGICZNY, 2013, 8 (04): : 262 - 267
  • [24] Indicators of suboptimal tumor necrosis factor antagonist therapy in inflammatory bowel disease
    Lindsay, James O.
    Armuzzi, Alessandro
    Gisbert, Javier P.
    Bokemeyer, Bernd
    Peyrin-Biroulet, Laurent
    Nguyen, Geoffrey C.
    Smyth, Michael
    Patel, Haridarshan
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (10) : 1086 - 1091
  • [25] Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update
    Leso, Veruscka
    Leggio, Lorenzo
    Armuzzi, Alessandro
    Gasbarrini, Giovanni
    Gasbarrini, Antonio
    Addolorato, Giovanni
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (07) : 779 - 786
  • [26] Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease
    Ordas, Ingrid
    Feagan, Brian G.
    Sandborn, William J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (10) : 1079 - 1087
  • [27] Study of tumor necrosis factor receptor in the inflammatory bowel disease
    Souza, Roberta Figueiroa
    Caetano, Marcos Antonio Ferreira
    Magalhaes, Henrique Inhauser Riceti
    Castelucci, Patricia
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (18) : 2733 - 2746
  • [28] Role of tumor necrosis factor-alpha (C-863A) polymorphism in pathogenesis of inflammatory bowel disease in Northern India
    Dinesh K. Ahirwar
    Pravin Kesarwani
    Ranjana Singh
    Uday Chand Ghoshal
    Rama Devi Mittal
    Journal of Gastrointestinal Cancer, 2012, 43 (2) : 196 - 204
  • [29] Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease
    Ágnes Vatay
    László Bene
    Ágota Kovács
    Zoltán Prohászka
    Csaba Szalai
    László Romics
    Béla Fekete
    István Karádi
    George Füst
    Immunogenetics, 2003, 55 : 247 - 252
  • [30] Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease
    Vatay, A
    Bene, L
    Kovács, A
    Prohászka, Z
    Szalai, C
    Romics, L
    Fekete, B
    Karádi, I
    Füst, G
    IMMUNOGENETICS, 2003, 55 (04) : 247 - 252